These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36725405)

  • 1. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.
    Jahreiß MC; Heemsbergen WD; Janus C; van de Pol M; Dirkx M; Dinmohamed AG; Nout RA; Hoogeman M; Incrocci L; Aben KKH
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e278-e288. PubMed ID: 36725405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study.
    Jahreiß MC; Heemsbergen WD; van Santvoort B; Hoogeman M; Dirkx M; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; van Oort IM; Bangma CH; Incrocci L; Aben KKH
    Front Oncol; 2021; 11():771956. PubMed ID: 34900722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
    Jahreiß MC; Hoogeman M; Aben KK; Dirkx M; Snieders R; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; Incrocci L; Heemsbergen WD
    Radiother Oncol; 2023 Jun; 183():109659. PubMed ID: 37003369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer.
    Jahreiß MC; Incrocci L; Aben KKH; De Vries KC; Hoogeman M; Hooning MJ; Heemsbergen WD
    Acta Oncol; 2024 Jun; 63():511-517. PubMed ID: 38946286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
    Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
    Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
    Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
    Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
    Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers in radically treated Norwegian prostate cancer patients.
    Aksnessæther BY; Lund JÅ; Myklebust TÅ; Klepp OH; Skovlund E; Roth Hoff S; Solberg A
    Acta Oncol; 2019 Jun; 58(6):838-844. PubMed ID: 30905229
    [No Abstract]   [Full Text] [Related]  

  • 13. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
    Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
    Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands.
    Evers J; Kerkmeijer LGW; van den Bergh RCN; van der Sangen MJC; Hulshof MCCM; Bloemers MCWM; Siesling S; Aarts MJ; Aben KKH; Struikmans H
    Radiother Oncol; 2022 Dec; 177():134-142. PubMed ID: 36328090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era.
    Jahreiß MC; Aben KKH; Hoogeman MS; Dirkx MLP; de Vries KC; Incrocci L; Heemsbergen WD
    Front Oncol; 2020; 10():605119. PubMed ID: 33282746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
    Jarosek SL; Virnig BA; Chu H; Elliott SP
    Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.
    Boorjian SA; Karnes RJ; Viterbo R; Rangel LJ; Bergstralh EJ; Horwitz EM; Blute ML; Buyyounouski MK
    Cancer; 2011 Jul; 117(13):2883-91. PubMed ID: 21692049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer.
    Zelefsky MJ; Housman DM; Pei X; Alicikus Z; Magsanoc JM; Dauer LT; St Germain J; Yamada Y; Kollmeier M; Cox B; Zhang Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):953-9. PubMed ID: 22172904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
    Andruska N; Agabalogun T; Fischer-Valuck BW; Brenneman RJ; Huang Y; Gay HA; Michalski JM; Carmona R; Baumann BC
    Brachytherapy; 2022; 21(5):617-625. PubMed ID: 35641370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.